Baradero, Chrislou Ann .

HRN: 20-27-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
CEFUROXIME 1.5GM (VIAL)
05/28/2023
05/29/2023
IV
1.5gm X 3 Doses
Q8
Post CS
Checking Final Appropriateness 
05/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/28/2023
05/29/2023
IV
500mg 3 Doses
Q8
Post Cs
Checking Final Appropriateness 
05/29/2023
CEFTRIAXONE 1G (VIAL)
05/29/2023
06/05/2023
IV
2gms
OD
CAP MR
Waiting Final Action 
05/29/2023
AZITHROMYCIN 500MG TABLET (TAB)
05/29/2023
06/02/2023
PO
500mg
OD
CAP MR
Waiting Final Action 
05/29/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/29/2023
06/04/2023
IVT
1.5g
Q6
Pneumonia
Checking Final Appropriateness 
05/29/2023
CEFTRIAXONE 1G (VIAL)
05/29/2023
06/04/2023
IVT
2g
OD
Pneumonia
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: